Browse All

Current Filters

CLEAR FILTER x

TITLE

MRI Evidence That Gadolinium-Enhancing Lesions Seen Twelve Weeks After Commencing Rituximab Treatment Are Associated with Lower Blood-Brain-Barrier Disruption Than Those Seen Prior to Treatment in Patients with Relapsing-Remitting Multiple Sclerosis